Blog

[Ebook] The top 3 delays that plague specialty prescribing — according to providers

[Ebook] The top 3 delays that plague specialty prescribing — according to providers

By ZappRx on January 22, 2016

There are many stakeholders and steps involved in getting a specialty drug “from pen to pill” - from the point at...

Read More
What’s next for specialty? Seven predictions for 2016

What’s next for specialty? Seven predictions for 2016

By ZappRx on January 07, 2016

2015 is in the rearview mirror, and in many ways, it was a year like no other for the specialty pharmaceutical...

Read More
Biosimilars: meet 2016’s solution to the specialty drug cost conundrum

Biosimilars: meet 2016’s solution to the specialty drug cost conundrum

By ZappRx on January 05, 2016

If you work in the pharma or biotech industry, you’ve probably heard the buzz about biosimilars. And, there’s a good...

Read More
Page 0 of 1
0 1
»